Drug Delivery
Reagents & Methods for Using Human Embryonic Stem Cells to Evaluate Developmental Toxicity for Pharmaceutical Compounds & Other Chemicals
WARF: P06130US
Inventors: Gabriela Cezar
The Invention
The invention provides biomarker profiles of cellular metabolites and methods for screening chemical compounds including pharmaceutical agents, lead and candidate drug compounds and other chemicals using human embryonic stem cells (hESC) or lineage-specific cells produced therefrom. The inventive methods are useful for testing toxicity, particularly developmental toxicity and detecting teratogenic effects of such chemical compounds.
Tech Fields
For current licensing status, please contact Andy DeTienne at [javascript protected email address] or 608-960-9857